LDLRAD4
Basic information
Region (hg38): 18:13217498-13652755
Previous symbols: [ "C18orf1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the LDLRAD4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 12 | 13 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 12 | 1 | 0 |
Variants in LDLRAD4
This is a list of pathogenic ClinVar variants found in the LDLRAD4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
18-13438289-C-T | not specified | Uncertain significance (Dec 17, 2023) | ||
18-13621128-T-C | not specified | Uncertain significance (Jul 11, 2023) | ||
18-13621231-G-A | Likely benign (Jan 01, 2023) | |||
18-13621234-C-T | not specified | Uncertain significance (Sep 23, 2023) | ||
18-13621246-G-A | not specified | Uncertain significance (Jan 09, 2024) | ||
18-13621267-C-T | not specified | Uncertain significance (May 10, 2022) | ||
18-13643386-G-A | not specified | Uncertain significance (May 31, 2024) | ||
18-13643402-G-A | not specified | Uncertain significance (Jul 25, 2023) | ||
18-13643408-C-T | not specified | Uncertain significance (Dec 16, 2022) | ||
18-13645143-G-A | not specified | Uncertain significance (Jul 20, 2021) | ||
18-13645187-C-T | not specified | Uncertain significance (May 24, 2023) | ||
18-13645227-A-G | not specified | Uncertain significance (Oct 26, 2022) | ||
18-13645436-A-T | not specified | Uncertain significance (Apr 05, 2023) | ||
18-13645473-G-A | not specified | Uncertain significance (Jun 10, 2024) | ||
18-13645503-G-T | not specified | Uncertain significance (Dec 16, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
LDLRAD4 | protein_coding | protein_coding | ENST00000361205 | 5 | 435258 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.620 | 0.378 | 125743 | 0 | 4 | 125747 | 0.0000159 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.57 | 137 | 200 | 0.686 | 0.0000128 | 2019 |
Missense in Polyphen | 44 | 83.369 | 0.52778 | 846 | ||
Synonymous | -0.189 | 88 | 85.8 | 1.03 | 0.00000631 | 603 |
Loss of Function | 2.63 | 2 | 11.7 | 0.171 | 6.71e-7 | 120 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000264 | 0.0000264 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Functions as a negative regulator of TGF-beta signaling and thereby probably plays a role in cell proliferation, differentiation, apoptosis, motility, extracellular matrix production and immunosuppression. In the canonical TGF-beta pathway, ZFYVE9/SARA recruits the intracellular signal transducer and transcriptional modulators SMAD2 and SMAD3 to the TGF-beta receptor. Phosphorylated by the receptor, SMAD2 and SMAD3 then form a heteromeric complex with SMAD4 that translocates to the nucleus to regulate transcription. Through interaction with SMAD2 and SMAD3, LDLRAD4 may compete with ZFYVE9 and SMAD4 and prevent propagation of the intracellular signal. {ECO:0000269|PubMed:24627487}.;
Recessive Scores
- pRec
- 0.0990
Intolerance Scores
- loftool
- rvis_EVS
- -0.12
- rvis_percentile_EVS
- 45.13
Haploinsufficiency Scores
- pHI
- 0.539
- hipred
- Y
- hipred_score
- 0.692
- ghis
- 0.504
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ldlrad4
- Phenotype
- immune system phenotype; hematopoietic system phenotype;
Gene ontology
- Biological process
- negative regulation of epithelial to mesenchymal transition;negative regulation of SMAD protein complex assembly;negative regulation of cell migration;negative regulation of transforming growth factor beta receptor signaling pathway;negative regulation of pathway-restricted SMAD protein phosphorylation
- Cellular component
- nucleoplasm;integral component of membrane;early endosome membrane;intracellular membrane-bounded organelle
- Molecular function
- R-SMAD binding